Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:3014-3016

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doevendans, P. A.
Right arrow Articles by Wellens, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doevendans, P. A.
Right arrow Articles by Wellens, H. J.

(Circulation. 2001;104:3014.)
© 2001 American Heart Association, Inc.


Editorials

Wolff-Parkinson-White Syndrome

A Genetic Disease?

Pieter A. Doevendans, MD; Hein J. Wellens, MD

From the Department of Cardiology, Academic Hospital Maastricht, Maastricht (P.A.D.), and the Interuniversity Cardiological Institute Netherlands, Utrecht (H.J.W.), the Netherlands.

Correspondence to Hein J. Wellens, MD, 21 Henric van Veldekeplein, 6211 TG Maastricht, The Netherlands. E-mail hwellens@xs4all.nl


Key Words: Wolff-Parkinson-White syndrome • Editorials • arrhythmias • genetics

The history of the Wolff-Parkinson-White (WPW) syndrome is a 50-year–long tale of speculation and discussion among physiologists, anatomists, and clinicians about how to explain the frequently occurring tachycardias in patients showing a strange ECG.1 That riddle was solved in 1967 in Amsterdam when Durrer and associates2 showed that the WPW syndrome was based on a second connection between the atrium and ventricle apart from the normal AV node–His pathway. The presence of conduction over such an accessory AV pathway was demonstrated by epicardial mapping during sinus rhythm. The crucial role of that structure in the tachycardia mechanism was proven by programmed electrical stimulation of the heart and mapping of cardiac activation by intracardiac catheters.3 It was shown that an impulse circulating in a circuit (consisting of atrium–AV node–His pathway–ventricle–accessory AV pathway) was responsible for the tachycardias usually found in these patients. Essential for initiation of the tachycardia is a difference in the electrophysiological properties of the 2 AV connections, which allows the occurrence of unidirectional block in 1 of the 2 structures. This difference can be exposed not only by critically timed atrial and ventricular premature beats but also by changes in the sinus rate (eg, during exercise). For perpetuation of the tachycardia, the circulation time of the impulse in the tachycardia circuit must be longer than the duration of the refractory period of the different parts of the tachycardia circuit.4

See p 3030

It also became clear that the anterograde refractory period of the accessory AV pathway determines the . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
L. Mestroni
Genomic medicine and atrial fibrillation
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2193 - 2196.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Jongbloed, C. L. Marcelis, P. A. Doevendans, J. M. Schmeitz-Mulkens, W. G. Van Dockum, J. P. Geraedts, and H. J. Smeets
Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy
J. Am. Coll. Cardiol., March 19, 2003; 41(6): 981 - 986.
[Abstract] [Full Text] [PDF]